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Introduction
Reperfusion therapy is the cornerstone of treatment
for patients with acute ST-elevation myocardial
infarction (STEMI). Timely reperfusion of the infarct-
related coronary artery using ﬁbrinolysis or PCI is
central to optimal STEMI treatment [1–3, 10, 15, 18].
As our treatment center has a skilled PCI laboratory
with an experienced interventional cardiologist on
duty 24 h a day, patients admitted to our hospital
undergo primary PCI if coronary arteries are suitable,
as recommend in current standard guidelines [1]
within <90 min door-to-balloon time.
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j Abstract Background Growing evidence suggests that poor coronary
blood ﬂow after primary percutaneous coronary intervention (PCI) is
associated with unfavorable clinical out-come. We retrospectively
evaluated data from our single center ‘‘real world patients’’ database of
patients undergoing primary PCI to determine differences in clinical and
angiographic patterns in patients with or without restoring thrombolysis
in myocardial infarction (TIMI) ﬂow 3. Methods and results Between
2001 and 2006, 500 patients underwent primary PCI for STEMI. In 430
patients, post-interventional TIMI ﬂow 3 could be established. In this
group, in-hospital mortality was signiﬁcant lower (6.4% Vs. 32.9%;
P < 0.0001), left ventricular ejection fraction was better (51.3 Vs. 44.2%;
P < 0.0001), and prehospital ﬁbrinolytic therapy (6.3% Vs. 14.3%;
P = 0.015), cardiogenic shock (10.9% Vs. 24.3%; P = 0.002) and use of
intra-aortic balloon pump were all more unlikely (5.8% Vs. 11.4%;
P = 0.045) compared to patients with TIMI ﬂow £ 2. In patients with
post-interventional TIMI ﬂow £ 2 the left anterior descending coronary
artery (LAD) was signiﬁcantly more often seen as the target vessel (54.3%
Vs. 44.6%; P = 0.039). A regressions analysis showed that predictors
leading to such ﬂow patterns are diabetes (P = 0.013), pre-hospital
ﬁbrinolytic therapy (P = 0.017), cardiogenic shock (P = 0.002) and a 3-
vessel disease (P = 0.003). After 6 months, patients without restored
normal TIMI ﬂow had worse New York Heart Association functional
class (NYHA), and had to undergo repeat coronary angiography more
often. Conclusion Post-interventional TIMI ﬂow £ 2 is strongly associ-
ated with adverse out-come during hospitalization and after 6 months
following hospitalization.
j Key words TIMI ﬂow – primary percutaneous coronary interven-
tion – acute myocardial infarction – follow up –
no reﬂow phenomenon
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Munich, GermanyThe beneﬁts of reperfusion therapy have been
attributed to the prompt reestablishment of normal
blood ﬂow in the infarct-related artery, deﬁned as
thrombolysis in myocardial infarction (TIMI) 3 ﬂow.
We investigated the clinical outcome at index
hospitalisation and after 6 months in groups of
patients with or without re-established TIMI three
ﬂow, using data from our acute PCI database of a
‘‘real world’’ outdoor patient cohort of 500 patients
treated between February 2001 and October 2006.
Methods
j Patient population
Results from 500 consecutive patients treated with
acute PCI in acute STEMI were retrospectively
acquired. STEMI was deﬁned as typical ischemic chest
pain within the previous 12 h and ST-segment ele-
vations of >2 mm in at least two contiguous leads.
All patients underwent acute coronary angiogra-
phy and, if eligible, direct or rescue angioplasty. All
interventions were performed according to current
standard guidelines [19–21].
As a pharmacological regimen, all patients received
500 mg Aspirin orally, 300 mg Clopidogrel and a
weight adapted bolus of intravenous heparin (100 IE/
kg) upon admission prior to entering the cathlab. A
weight-adapted bolus (0.25 mg/kg) of abciximab
(Reopro
 , Lilly Corp) was also administered in all
patients, with the exception of those who received
prehospital ﬁbrinolytic therapy. Administration of
abciximab was established in our center as good
clinical practice after data of positive impact in pa-
tients undergoing primary PCI came up [7, 9, 11].
Other medications, including betablockers, nitrates,
and morphine were administered at the discretion of
the physician on duty.
The antegrade radiocontrast ﬂow of the infarct-
related artery was determined on the ﬁnal coronary
angiogram by the operator with the use of TIMI cri-
teria. The TIMI ﬂow grades have been deﬁned pre-
viously [22]. In brief, grade 0 perfusion is no
antegrade ﬂow beyond the point of occlusion; grade 1
is minimal incomplete perfusion of contrast medium
around the clot; grade 2 (partial perfusion) is com-
plete but delayed perfusion of the distal coronary bed
with contrast material; and grade 3 (complete perfu-
sion) is antegrade ﬂow to the entire distal bed at a
normal rate.
All patients were invited for a follow-up visit
6 months after index hospitalisation. Clinical status
and 12 lead ECGs were performed routinely. An
exercise test was also performed at the discretion of
the physician.
j Statistical analysis
A multivariate binary logistic regression analysis was
performed to determine which clinical and angio-
graphic variables would independently predict poor
post-interventional coronary ﬂow (TIMI ﬂow £ 2).
Variables with a P-value < 0.05 were considered sta-
tistically signiﬁcant as independent predictors.
Values are expressed as mean ± standard devia-
tion or frequencies. Differences in continuous
variables were analyzed using the Student’s t test.
P-values < 0.05wereconsideredstatisticallysigniﬁcant.
Results
j Baseline characteristics
The baseline characteristics are listed in Table 1. Five
hundred patients underwent primary angioplasty for
myocardial infarction. In all, 70 patients (14%), 21
(30%) female, did not show TIMI 3 ﬂow after inter-
vention. The number of patients with TIMI 0.1, and
two ﬂows were 32 patients (46%), 12 patients (17%)
and 26 patients (37%) respectively. In 430 patients
(86%), 111 female (25.8%), the procedure was con-
sidered complete after establishing TIMI 3 ﬂow. In
419 out of the 430 patients with post procedural TIMI
3 ﬂow, TIMI 3 ﬂow was established by PCI. In 11
patients (2.6%) angioplasty was not performed for
various reasons. In three patients, a pericarditis was
diagnosed. Seven patients did not show angiographic
stenosis ‡50%. These 10 patients (2%) were excluded
from our analysis because no signiﬁcant stenosis in
Table 1 Baseline characteristics of patients undergoing acute coronary angi-
ography
TIMI flow = 3
(n = 430)
TIMI flow £ 2
(n = 70)
P-value
n (%) n (%)
Age (SD); years 61 (13) 64 (14) 0.049
Female 111 (25.8) 21 (30) 0.086
Onset of symptom
to hospital (SD), min
292.6 (527.9) 341.9 (558.7) 0.231
History
Hypertension 230 (53.5) 32 (45.7) 0.05
Diabetes 58 (13.5) 19 (27.1) 0.003
Hypercholesterolemia 216 (50.2) 38 (54.3) 0.084
Prior PCI or myocardial infarction 123 (28.6) 18 (25.7%) 0.103
Prior bypass surgery 13 (3.0) 5 (7.1) 0.064
Current tobacco smoker 135 (31.4) 20 (28.5) 0.101
Prehospital thrombolytic therapy 27 (6.3) 10 (14.3) 0.015
Clinical presentation
Killip class > 1 203 (47.2) 40 (57.1) 0.032
Cardiogenic shock 47 (10.9) 17 (24.3) 0.002
SD standard deviation, PCI percutaneous coronary intervention
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coronary morphology was not suitable for PCI and
was therefore sent for acute coronary artery bypass
grafting (CABG).
Of the 70 patients with post procedural TIMI
ﬂow £ 2, PCI was performed in 57 patients. 13 patients
did not undergo angioplasty for various reasons. In 10
cases, PCI was not performed for technical reasons
and patients were treated conservatively. One patient
exhibited a closed Ramus obliquus as the target vessel,
which was therefore not suitable for PCI. One patient
was sent for acute coronary artery bypass grafting
(CABG) as a result of a left main stem stenosis in a
three vessels disease. In another patient, peripheral
coronary embolism lead to ischemia and the vessel
was not suitable for PCI. The interventional success
rate was 82.6% in this cohort. The overall success rate
was 97.6% (476 patients out of 488).
Compared with the cohort with TIMI 3 ﬂow, those
with TIMI ﬂow £ 2 were signiﬁcantly more likely to
be older, diabetic, hypertensive, and had unsuccessful
prehospital ﬁbrinolytic therapy with an indication for
a ‘‘rescue PCI’’. Similarly, presentation with cardio-
genic shock, deﬁned as adverse hemodynamics such
as heart rate >100 beats/min and blood pressure
<100 mmHg, despite adequate ﬂuid administration,
was more common in patients with TIMI ﬂow £ 2.
There was also a trend towards a longer period of
chest pain in patients with post-interventional TIMI
ﬂow £ 2. However, due to a large standard deviation,
a statistically signiﬁcant difference was not observed.
j Angiographic results and clinical outcome
Angiographic characteristics differed between the two
patient groups. In this analysis, only those patients
with signiﬁcant coronary artery stenosis (n = 490)
were included. As mentioned previously, ten patients
did not undergo revascularisation (Tables 2 and 3).
Thus, patients with TIMI ﬂow £ 2 were more likely
to have initial TIMI ﬂow £ 1( P = 0.015), left anterior
descending and saphenous vein grafts as infarct-re-
lated artery, a left ventricular ejection fraction <50%,
and were more likely to undergo rescue PCI after
prehospital intravenous thrombolytic therapy and
treatment with an intra-aortic balloon pump
(P = 0.045).
There was a signiﬁcant difference observed in
overall mortality during index hospitalization be-
tween patients who achieved TIMI ﬂow £ 2 and TIMI
ﬂow 3 (32.9 Vs. 6.4%, P < 0.0001) after their primary
PCI. Follow-up mortality after 6 months was not
statistically different between the two groups.
However, presentation of New York heart associ-
ation classiﬁcation (NYHA-Class) at the 6-month
follow-up visit was signiﬁcantly different. Patients
with TIMI ﬂow £ 2 were more likely to present in
NYHA class ‡1 and to undergo repeated coronary
angiography. However, target vessel revascularisation
in these catheterizations was performed more often in
the patients with post-interventional TIMI ﬂow 3
(P = 0.025).
Table 2 Angiographic data of patients showing significant coronary artery
stenosis
TIMI flow = 3
(n = 420)
TIMI flow £ 2
(n = 70)
P-value
n (%) n (%)
Infarct-related artery
Left anterior descending 190 (45.2) 38 (54.3) 0.039
Left circumflex 67 (16) 10 (14.3) 0.137
Right coronary 152 (36.2) 17 (24.3) 0.016
Saphenous vein graft 6 (1.4) 4 (5.7) 0.033
Left main 5 (1.2) 1 (1.4) 0.399
Three vessels disease 76 (18.1) 19 (27.1) 0.027
Initial TIMI flow
0 265 (63.1) 49 (70) 0.059
1 62 (14.8) 13 (18.6) 0.097
2 52 (12.4) 8 (11.4) 0.155
3 41 (9.7) 0 (0) 0.0013
Post-procedure TIMI flow
0 0 (0) 32 (45.7)
1 0 (0) 12 (17.1)
2 0 (0) 26 (37.2)
3 420 (100) 0 (0)
Intra-aortic balloon pump 25 (5.9) 8 (11.4) 0.045
Stentthrombosis 34 (7.9) 6 (8.6) 0.179
Left ventricular ejection
fraction (SD)
51.3 (11.8) 44.2 (13.1) 0.00001
SD standard deviation, TIMI thrombolysis in myocardial infarction
Table 3 Follow up data
TIMI Flow = 3
(n = 420)
TIMI Flow £ 2
(n = 70)
P-value
n (%) n (%)
In hospital mortality 27 (6.4) 23 (32.9) <0.0001
6 month follow up 393 47
Lost of follow up 18 (4.5) 3 (6.4)
Death 17 (4.2) 2 (4.3) 0.293
NYHA I 183 (51.1) 16 (38.1) 0.037
NYHA II 122 (34.1) 21 (50.0) 0.018
NYHA III 42 (11.7) 3 (7.1) 0.155
NYHA IV 11 (3.1) 2 (4.8) 0.258
Cardiac catheterization 133 (37.2) 23 (54.7) 0.012
TVR 52 (39.1) 4 (17.4) 0.025
PCI of non target vessel 22 (16.6) 4 (17.4) 0.232
ad CABG 4 (3.0) 0
NYHA New York Heart Association, TVR target vessel revascularization, PCI
percutaneous coronary intervention, CABG coronary artery bypass grafting, TIMI
thrombolysis in myocardial infarction
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Resorting to stepwise logistic regression, four inde-
pendent predictors of TIMI ﬂow £ 2 were identiﬁed:
prehospital thrombolytic therapy, cardiogenic shock,
three vessel disease, and diabetes mellitus. The most
powerful predictors were cardiogenic shock and three
vessel disease. Prehospital thrombolytic therapy and
diabetes mellitus were also associated with a higher
probability of a TIMI ﬂow £ 2. The overall predict-
ability of the regression model was 85.8% (Table 4).
Discussion
Successful reperfusion therapy, achieved through
mechanical or pharmacological intervention, is the
goalinthetreatmentofpatientswithSTEMI[3,10,18].
The objective of all interventions is restoration of
normal TIMI 3 ﬂow within the epicardial coronary
vessels. Time to reperfusion is an important factor in
this topic, as described previously [5, 23]. This could
give an account for worse outcome in patients after
unsuccessful prehospital ﬁbrinolytic therapy with
an indication for a ‘‘rescue PCI’’. Rescue patients
evolve larger infarctions, likely explained by delay to
reperfusion [4]. On the other hand we did not
administer abciximab in these patients which might
additionally have an impact on TIMI ﬂow and clinical
outcome. For this topic further investigation is needed
in order to establish therapeuticalregimen with GPIIb/
IIIa antagonists on top of a failed thombolytic therapy.
The study populations in previously published
data discussing the inﬂuence of TIMI ﬂow on angio-
graphic and clinical results are different from the
study population evaluated here. Previous studies
excluded patients after prehospital ﬁbrinolysis, and
patients with cardiogenic shock, renal insufﬁciancy,
or those with child-bearing potential (unless the result
of a recent pregnancy test was negative) [12], or
compared different therapeutical regimens [6].
We present data of a single center ‘‘real world
cohort’’ of 500 patients admitted to our hospital with
STEMI. As PCI was attempted in many patients that
would have been excluded in former randomized tri-
als, restoration was not feasible in all patients despite
high levels of technical experience amongst the oper-
ators, as an overall success rate of 97.6% indicates.
Putative mechanisms for suboptimal post-interven-
tional epicardial coronary ﬂow, known as ‘‘no reﬂow
phenomenon’’, may be a multi-factor condition
reﬂecting damage to microvascular integrity incurred
both during ischemia and at the time of reperfusion.
Possible related factors are microvascular damage or
edema, neutrophil plugging of the microvessels, mi-
corovascular spasm, distal embolization of thrombus,
anddebris,orpoorPCIresultwithasigniﬁcantresidual
stenosis,dissection,ormuralthrombosis[13,14,16,17].
The post-interventional TIMI ﬂow is an important
prognostic value for in-hospital mortality and clinical
outcome 6 months post-hospitalization [8].
This analysis of a ‘‘real world patient cohort’’
demonstrates that the success rate of primary PCI is
lower in older patients than in younger patients, and
this ﬁnding is associated with a higher mortality with
primary PCI during STEMI in elderly patients. In
addition, patients with STEMI showing the left ante-
rior descending coronary artery or saphenous vein
grafts as the culprit vessel are more likely to have
poor ﬁnal coronary blood ﬂow.
Overall, age, clinical presentation, and infarct
localization appear to be important factors impacting
the outcome in patients with STEMI undergoing pri-
mary PCI. Predictors for poor post-interventional
ﬂow in the coronary arteries are three vessels disease,
cardiogenic shock, diabetes mellitus, and inefﬁcient
prehospital thrombolytic therapy.
A ﬁnding that has not been previously described is
that patients undergoing rescue PCI due to inefﬁcient
intravenous ﬁbrinolytic therapy have a post-inter-
ventional TIMI ﬂow £ 2 signiﬁcantly more often.
These ﬁndings warrant further evaluation. It is most
plausible that the mechanisms described above result
in impaired ﬂow in the coronary arteries if pharma-
cological reperfusion is not successful.
Patients with TIMI ﬂow £ 2 exhibited worse NYHA
class at the 6 month follow-up visit, requiring coro-
nary angiography more frequently at this timepoint in
order to obtain invasive control. However, the rate of
targetvesselrevascularisationfollowingthedecisionto
obtain invasive control at the 6 month follow-up visit
was signiﬁcantly lower in these patients. This may, on
the one hand, be the result of the higher incidence of
three vessel disease in these patients, without the need
for another PCI (total chronic occlusion; no angio-
graphic signiﬁcant stenosis (<60%)). On the other
hand, as is the case in this patient group, age is asso-
ciated with higher levels of sclerosis in the small lumen
diameter vessels, without the possibility of mechanical
Table 4 Logistic regression analysis for independent predictors of postinter-
ventional TIMI flow £ 2
Variable Beta
coefficient
Standard
error
P-value Odds
ratio
95% confidence
intervall
Cardiogenic shock 0.993 0.326 0.002 2.700 1.425–5.116
Three vessel disease 0.877 0.294 0.003 2.404 1.351–4.277
Prehospital thrombolytic
therapy
0.976 0.408 0.017 2.653 1.191–5.906
Diabetes mellitus 0.781 0.316 0.013 2.185 1.176–4.060
Constant )2.482 0.201 <0.001 0.084
TIMI thrombolysis in myocardial infarction
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follow up.
Conclusion
The inability to achieve successful coronary reperfu-
sion is associated with a higher mortality in patients
with acute myocardial infarction undergoing primary
angioplasty. Prehospital ﬁbrinolytic therapy, age, and
infarct localisation increase the risk of poor ﬁnal
coronary blood ﬂow. Post- interventional TIMI
ﬂow £ 2 is associated with a worse NYHA class at a
6 month follow-up visit, requiring a signiﬁcantly
higher number of repeated coronary angiograms to
assess invasive coronary status.
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